People: Keryx Biopharmaceuticals, Inc. (KERX.O)

James F. Oliviero has served as Chief Financial Officer of Keryx Biopharmaceuticals, Inc. since April 2009 and previously served as Vice President, Finance since March 2008. He also serves as Treasurer and Corporate Secretary of Keryx Biopharmaceuticals, Inc. From May 2003 until March 2008, Mr. Oliviero served as Keryx’s Controller, where he was involved in all capital raising, licensing and acquisition transactions. Since joining Keryx, Mr. Oliviero has also been in charge of Keryx’s compliance with Securities and Exchange Commission rules and regulations and other corporate governance matters. From August 1999 until May 2003, Mr. Oliviero served as Director of Finance for ACCESS Oncology, Inc., a privately-held biotechnology company. From July 1997 to August 1999, Mr. Oliviero was an investment banker at ING Barings Furman Selz in New York City, where he worked on various mergers and acquisitions and equity and debt transactions. Mr. Oliviero holds a B.B.A. in Finance with Highest Distinction from Emory University’s Goizueta Business School.